Total Funding
35
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
120129
Brava Diagnostics develops and commercializes acute care diagnostic products based on the MBio diagnostics rapid testing platform.
Acquired by 
LightDeck Diagnostics
Byron D. Hewett: Founder and CEOPast Role: SomaLogic, CEO- David Okrongly: Co-founder and Chief Operating Officer
About the Company
Brava Diagnostics develops and commercializes acute care diagnostic products based on the MBio diagnostics rapid testing platform. It is seeking seed financing to fund product development for rapid multiplex point-of-care tests for acute care settings.
The core platform uses evanescent planar waveguide technology was developed by MBio. Products
have been commercialized for applications outside of human health. Brava's in-vitro diagnostics applications will be for cardiac markers, a $2.3 billion worldwide market. Our first indications will be to assess chest pain and shortness of breath in the emergency department. The next assays will address sepsis, the highest cost disease state in U.S. health systems.
Women Founded
